Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027)

the ACCESS and SESSA Research Groups

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027)'. Together they form a unique fingerprint.

Medicine & Life Sciences